It is the cache of http://www.joplink.net/prev/200107/10.html. It is a snapshot of the page. The current page could have changed in the meantime.
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

Gray MA, et al. Functional Interactions of HCO3- with Cystic Fibrosis Transmembrane Conductance Regulator. JOP. J Pancreas (Online) 2001; 2(4 Suppl):207-211. [Full text]

International Symposium on "HCO3- AND CYSTIC FIBROSIS". San Diego, CA (USA). March 3-5, 2001.

  Article in PDF format  -  JOP Home page

JOP. J Pancreas (Online) 2001; 2(4 Suppl):207-211.

Functional Interactions of HCO3- with Cystic Fibrosis Transmembrane Conductance Regulator

Mike A Gray, Catherine O’Reilly1, John Winpenny2, Barry Argent

Department of Physiological Sciences, University Medical School. Newcastle upon Tyne, United Kingdom. 1Biomedical Imaging Group, Department of Physiology, University of Massachusetts Medical Centre. Worcester, MA, USA. 2School of Health Sciences, University of Sunderland. Sunderland, United Kingdom

Summary

Disruption of normal cystic fibrosis transmembrane conductance regulator- (CFTR)-mediated Cl- transport is associated with cystic fibrosis (CF). CFTR is also required for HCO3- transport in many tissues such as the lungs, gastro-intestinal tract, and pancreas, although the exact role CFTR plays is uncertain. Given the importance of CFTR in HCO3- transport by so many CF-affected organ systems, it is perhaps surprising that relatively little is known about the interactions of HCO3- ions with CFTR. We have used patch clamp recordings from native pancreatic duct cells to study HCO3- permeation and interaction with CFTR. Ion selectivity studies shows that CFTR is between 3-5 times more selective for Cl- over HCO3-. In addition, extracellular HCO3- has a novel inhibitory effect on cAMP-stimulated CFTR currents carried by Cl-. The block by HCO3- was rapid, relatively independent of voltage and occurred over the physiological range of HCO3- concentrations. These data show that luminal HCO3- acts as a potent regulator of CFTR, and suggests that inhibition involves an external anion-binding site on the channel. This work has implications not only for elucidating mechanisms of HCO3- transport in epithelia, but also for approaches used to treat CF.


It is well established that cystic fibrosis transmembrane conductance regulator (CFTR) transports chloride ions in a variety of epithelial tissues. Disruption of normal CFTR-mediated Cl- transport is associated with a number of diseases such as cystic fibrosis (CF), certain types of secretory diarrhoea, and possibly polycystic kidney disease. CFTR is also involved in the transport of other physiologically important anions such as HCO3- [1], glutathione [2] and larger organic anions [3]. In the case of HCO3- many epithelial tissues secrete this anion by a mechanism which is dependent on functional CFTR channels. This has been observed in the airways [4], including submucosal glands [5]; the gastro-intestinal tract [6]; the liver and gallbladder [7, 8] and the pancreas [9], the archetypal bicarbonate-transporting gland. While there is now strong evidence that CFTR is essential for effective HCO3- secretion the exact role it plays is still uncertain.

Our studies have focused on the role of CFTR in the production of an HCO3- rich alkaline secretion by the exocrine pancreas [1]. We proposed back in 1988 that HCO3- exits across the apical membrane of pancreatic duct cells (PDCs) by parallel operation of CFTR Cl- channels and Cl-/HCO3- exchangers [10]. In this scheme the CFTR channel can be viewed as having two functions. The first is to provide luminal Cl- for operation of the anion exchangers. The second is to act as a leak pathway to dissipate intracellular Cl- accumulated as the exchanger cycle. Implicit in this ‘CFTR-anion exchanger model’ is that CFTR is better at transporting Cl- than HCO3- under normal physiological conditions.

We showed this to be the case in subsequent patch clamp studies using both single channel [11] and whole cell current recordings [12], of CFTR in native rat pancreatic duct cells. However, it should be noted that in all cases CFTR did demonstrate a low but measurable permeability to HCO3-. Therefore, under conditions where intracellular Cl- is at or near electrochemical equilibrium then it is possible that CFTR could act as an exit pathway for HCO3-. With this in mind our computer modeling studies indicate that parallel operation of CFTR channels and Cl-/HCO3- exchangers cannot support the secretion of a pancreatic juice containing near isotonic NaHCO3, as occurs in most other species [13]. Secretory studies on isolated guinea-pig ducts have also shown that HCO3- secretion can occur in the virtual absence of extracellular Cl- which would not be predicted for the CFTR – anion exchanger model [14, 15]. The implication of these findings is that species such as cat, dog, pig, guinea-pig and human, all of which secrete a pancreatic juice with a high HCO3- content (about 150 mM), employ a different secretory mechanism to that originally suggested for the rat, but which is still dependent on CFTR (see the chapter by Sohma et al. which discusses this in more detail [16]).

Extracellular HCO3- Blocks Cl- Efflux through CFTR

During recent anion permeability studies from native guinea pig PDCs, we observed an unexpected and novel effect of extracellular HCO3- on cAMP-activated CFTR Cl- currents [17]. Figure 1 shows that when 140 mM extracellular Cl- is replaced by HCO3- this resulted in a marked inhibition of CFTR currents. While the reduction in outward current (anion influx) was expected because of the decrease in extracellular Cl- concentration, the marked block of inward current (anion efflux) was not predicted as pipette Cl- concentration was unchanged. The reduced inward current indicates that external HCO3- is causing ‘trans’ inhibition of Cl- efflux.

Figure 1. Inhibition of cAMP-activated currents by bath HCO3-.
Whole cell currents were recorded at room temperature under control conditions (a) or after exposure to stimulants (5 m M forskolin and 100 m M dibutyryl cAMP) that activate PKA (b and c). Whole cell currents were obtained by holding the membrane potential (Vm) at 0 mV and clamping Vm to ±100 mV in 20 mV steps. The pipette solution contained (mM): 110 CsCl, 2 MgCl2, 5 ethyleneglycol-bis-(beta-aminoethyl ether)-N,N'-tetraacetic acid (EGTA), 10 N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), 1 Na2ATP, pH 7.2 with CsOH. The bath solution contained (mM): 145 NaCl, 4.5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, 5 Glucose, pH 7.4 or in (c), 140mM NaCl was replaced with NaHCO3 and CaCl2 was omitted from the solution (pH about 8.0). For further details on cell preparation and electrophysiology see [17].

This effect of extracellular HCO3- was rapid, fully reversible (Figure 2a) and dose-dependent over a physiological range of extracellular HCO3- concentrations (Figure 2b).

The data in Figure 2b suggest that a single binding site is involved in the HCO3- induced inhibition of inward current flow. Since inhibition was only weakly voltage-dependent (Figures 1 and 2a), this site is unlikely to experience the voltage drop across the channel.

Figure 2. Reversible and concentration-dependent block of CFTR by extracellular HCO3-.
(a) Summary of the effect of 140 mM external HCO3- on the size of cAMP-activated CFTR Cl- currents. Same conditions as Figure 1. Current density was calculated by dividing the total current by cell capacitance. Data measured at the reversal potential (Erev) ± 60 mV and was obtained from current/voltage plots of the data in Figure 1.
(b) Effect of different extracellular HCO3- concentrations on inward current inhibition. Data measured at Erev –60 mV and fitted to a Michaelis-Menten equation with the parameters indicated on the figure (diagram adapted from O'Reilly CM et al., with permission [17]).

We next investigated which component of the HCO3- containing solutions, pH, HCO3- or pCO2, was responsible for the observed current inhibition. By varying intra and extracellular pH over a wide range (6.2-8.0), and changing pCO2 fourfold (3-12 kPa) while maintaining a concentration of HCO3- that caused maximal inhibition, we were able to conclude that it is the HCO3- ion itself that inhibits CFTR [17].

Although our experiments have not identified how HCO3- is able to block CFTR we think that an external anion-binding site is involved. We speculate that a positively charged site (arginine, lysine or possibly histidine) in the extracellular loops (EL) of CFTR could be involved (Figure 3). For example in EL1 of human CFTR residues R104 and R117 are conserved amongst all species, and R117H is a known disease causing mutation. Our current research is aimed at testing this hypothesis. It should also be noted that HCO3- is not unique in being able to inhibit Cl- movement through CFTR, since both extracellular I- and ClO4- also cause a significant reduction in inward current, but with less affinity than HCO3-, and in the case of iodide, irreversibly [17].

Figure 3. Positively charged residues in the extracellular loops (EL) of human CFTR. Abbreviations used. H: Histidine, K: Lysine and R: Arginine.

Physiological Implications of HCO3- Inhibition of CFTR

At first sight an inhibitory effect of extracellular HCO3- on CFTR appears paradoxical in that it would inhibit HCO3- secretion. At the maximum concentration of HCO3- found in guinea-pig pancreatic juice (about 150 mM) the CFTR conductance would be more than 70% blocked (Figure 2). However, it is notable that in guinea pig ducts basal HCO3- secretion is Cl- dependent and blocked by 4,4'-diisothiocyanatostilbene-2,2'-disulphonic acid (DIDS), suggesting that it occurs via Cl-/HCO3- exchange [13, 14]. In contrast, cAMP-stimulated HCO3- secretion is unaffected by removal of extracellular Cl- and must therefore involve some other pathway [13, 14]. That pathway is likely to be CFTR. Inhibiting the CFTR conductance via a negative feedback mechanism from ‘signals’ in the lumen of the pancreatic ducts may be advantageous in that it would limit apical membrane depolarisation and maintain the electrical driving force for HCO3- secretion via the uninhibited fraction of CFTR. Since many other organ systems (liver, gastro-intestinal tract and lungs) also secrete HCO3-, this suggests that HCO3- concentration at the luminal surface of epithelial cells plays a general role in the regulation of CFTR, as well as providing an appropriate physiological environment for these tissues to operate normally.

References

  1. Argent BE, Gray MA. Regulation and formation of fluid and electrolyte secretions by pancreatic ductal epithelium. In: Sirica AE, Longnecker DS, eds. Biliary and Pancreatic Ductal Epithelia. Pathobiology and Pathophysiology. New York, NY, USA: Marcel Dekker, 1997: 349-77. [More details]

  2. Linsdell P, Hanrahan JW. Glutathione permeability of CFTR. Am J Physiol 1998; 275:C323-6. [More details]

  3. Linsdell P, Hanrahan JW. ATP-dependent asymmetry of anion permeation in the cystic fibrosis transmembrane conductance regulator chloride channel. J Gen Physiol 1998; 111:601-14. [More details]

  4. Smith JJ, Welsh MJ. cAMP stimulates bicarbonate secretion across normal but not cystic fibrosis airway epithelia. J Clin Invest 1992;89:1148-53. [More details]

  5. Ballard ST, Trout L, Bebok Z, Sorscher EJ, Crews A. CFTR involvement in chloride, bicarbonate, and liquid secretion by airway submucosal glands. Am J Physiol 1999; 277:L694-9. [More details]

  6. Hogan DL, Crombie DL, Isenberg JI, Svendsen P, Schaffalitzky de Muckadell OB, Ainsworth MA. CFTR mediates cAMP- and Ca2+-activated duodenal epithelial HCO3- secretion. Am J Physiol 1997; 272:G872-8. [More details]

  7. Fitz JG, Cohn JA. Biology and pathophysiology of CFTR and other Cl- channels in biliary epithelial cells. In: Sirica AE, Longnecker DS, eds. Biliary and Pancreatic Ductal Epithelia. Pathobiology and Pathophysiology. New York, NY, USA: Marcel Dekker, 1997: 107-25. [More details]

  8. Curtis CM, Martin LC, Higgins CF, Colledge WH, Hickman ME, Evans MJ, et al. Restoration by intratracheal gene transfer of bicarbonate secretion in cystic fibrosis mouse gallbladder. Am J Physiol 1998; 274:G1053-60. [More details]

  9. Durie PR, Forstner GG. Pathophysiology of the exocrine pancreas in cystic fibrosis. J R Soc Med 1989; 82 (Suppl. 16):2-10. [More details]

  10. Gray MA, Greenwell JR, Argent BE. Secretin-regulated chloride channel on the apical plasma membrane of pancreatic duct cells. J Membr Biol 1988; 105:131-42. [More details]

  11. Gray MA, Pollard CE, Harris A, Coleman L, Greenwell JR, Argent BE. Anion selectivity and block of the small conductance chloride channel on pancreatic duct cells. Am J Physiol 1990; 259:C752-61. [More details]

  12. Gray MA, Plant S, Argent BE. Cyclic AMP-regulated whole-cell chloride currents in pancreatic duct cells. Am J Physiol 1993; 264:C591-602. [More details]

  13. Sohma Y, Gray MA, Imai Y, Argent BE. A mathematical model of the pancreatic ductal epithelium. J Membr Biol 1996; 154:53-67. [More details]

  14. Ishiguro H, Steward MC, Wilson RW, Case RM. Bicarbonate secretion in interlobular ducts from guinea-pig pancreas. J Physiol 1996; 495:179-91. [More details]

  15. Ishiguro H, Naruse S, Steward MC, Kitagawa M, Ko SB, Hayakawa T, Case RM. Fluid secretion in interlobular ducts isolated from guinea-pig pancreas. J Physiol 1998; 511:407-22. [More details]

  16. Sohma Y, Gray MA, Imai I, Argent BE. 150 mM HCO3- - How does the pancreas do it? Clues from computer modelling of the duct cell. JOP. J Pancreas (Online) 2001; 2(4 Suppl.): 198-202. [More details]

  17. O'Reilly CM, Winpenny JP, Argent BE, Gray MA. Cystic fibrosis transmembrane conductance regulator currents in guinea-pig pancreatic duct cells and their inhibition by bicarbonate ions. Gastroenterology 2000; 118:1187-96. [More details]

Article in PDF format
Look up who cited this article


Key words Chloride Channels; Cystic Fibrosis; Ion Transport; Pancreas; Sodium Bicarbonate

Abbreviations CF: cystic fibrosis; CFTR: cystic fibrosis transmembrane conductance regulator; DIDS: 4,4'-diisothiocyanatostilbene-2,2'-disulphonic acid; EGTA: ethyleneglycol-bis-(beta-aminoethyl ether)-N,N'-tetraacetic acid; EL: extracellular loops; HEPES: N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid; PDC: pancreatic duct cell

Acknowledgements Funded by grants from the Cystic Fibrosis Trust (UK) and the Wellcome Trust.

Correspondence
Mike A Gray
Department of Physiological Sciences
University Medical School
Framlington Place
Newcastle upon Tyne NE2 4HH
United Kingdom
Phone: 44-191-222.7592
Fax: +44-191-222.6706
E- mail address: m.a.gray@ncl.ac.uk

JOP Home page